VTRS
Price
$9.61
Change
+$0.01 (+0.10%)
Updated
Sep 16, 11:24 AM (EDT)
Capitalization
11.19B
55 days until earnings call
Interact to see
Advertisement

VTRS

Header iconVTRS Comparison
Open Charts VTRSBanner chart's image
Viatris
Price$9.61
Change+$0.01 (+0.10%)
Volume$6.82K
Capitalization11.19B
VTRS Comparison Chart in %
Loading...
VTRS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are ZOETIS (NYSE:ZTS), Teva Pharmaceutical Industries Limited (NYSE:TEVA), Elanco Animal Health (NYSE:ELAN), Bausch Health Companies (NYSE:BHC), BioCryst Pharmaceuticals (NASDAQ:BCRX), Avadel Pharmaceuticals plc (NASDAQ:AVDL), Tilray Brands (NASDAQ:TLRY), Canopy Growth Corp (NASDAQ:CGC), Aurora Cannabis (NASDAQ:ACB), Journey Medical Corp (NASDAQ:DERM).

Industry description

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

Market Cap

The average market capitalization across the Pharmaceuticals: Generic Industry is 3.9B. The market cap for tickers in the group ranges from 5.57K to 64.82B. ZTS holds the highest valuation in this group at 64.82B. The lowest valued company is BGPPF at 5.57K.

High and low price notable news

The average weekly price growth across all stocks in the Pharmaceuticals: Generic Industry was 27%. For the same Industry, the average monthly price growth was 28%, and the average quarterly price growth was 64%. INNPD experienced the highest price growth at 6,227%, while RGTLF experienced the biggest fall at -91%.

Volume

The average weekly volume growth across all stocks in the Pharmaceuticals: Generic Industry was -50%. For the same stocks of the Industry, the average monthly volume growth was -33% and the average quarterly volume growth was -1%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 52
P/E Growth Rating: 65
Price Growth Rating: 55
SMR Rating: 83
Profit Risk Rating: 91
Seasonality Score: -17 (-100 ... +100)
Interact to see
Advertisement
COMPARISON
Comparison
Sep 16, 2025
Stock price -- (VTRS: $9.60)
Brand notoriety:
Market capitalization --

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

VTRS’s FA Score shows that 2 FA rating(s) are green while.

  • VTRS’s FA Score: 2 green, 3 red.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

VTRS’s TA Score shows that 5 TA indicator(s) are bullish.

  • VTRS’s TA Score: 5 bullish, 4 bearish.

Price Growth

VTRS (@Pharmaceuticals: Generic) experienced а -8.40% price change this weekfor the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +27.19%. For the same industry, the average monthly price growth was +27.89%, and the average quarterly price growth was +64.03%.

Reported Earning Dates

VTRS is expected to report earnings on Nov 10, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+27.19% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VTRS
Capitalization11.2B
EBITDA-493.3M
Gain YTD-19.903
P/E Ratio236.20
Revenue14.1B
Total Cash809M
Total Debt14.8B
FUNDAMENTALS RATINGS
VTRS: Fundamental Ratings
VTRS
OUTLOOK RATING
1..100
60
VALUATION
overvalued / fair valued / undervalued
1..100
12
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
55
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
VTRS
RSI
ODDS (%)
Bullish Trend 1 day ago
62%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
57%
Momentum
ODDS (%)
Bearish Trend 1 day ago
62%
MACD
ODDS (%)
Bearish Trend 1 day ago
64%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
63%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
62%
Advances
ODDS (%)
Bullish Trend 15 days ago
68%
Declines
ODDS (%)
Bearish Trend 1 day ago
65%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
54%
Aroon
ODDS (%)
Bullish Trend 1 day ago
68%
View a ticker or compare two or three
Interact to see
Advertisement
VTRS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
ADME50.610.16
+0.32%
Aptus Drawdown Managed Equity ETF
PBSE28.820.05
+0.18%
PGIM S&P 500 Buffer 20 ETF - Sep
PDEC41.750.05
+0.12%
Innovator U.S. Eq Power Buffer ETF - Dec
ZTOP52.66N/A
N/A
F/m High Yield 100 ETF
VPC20.27-0.22
-1.10%
Virtus Private Credit ETF

VTRS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, VTRS has been loosely correlated with ELAN. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if VTRS jumps, then ELAN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VTRS
1D Price
Change %
VTRS100%
-3.61%
ELAN - VTRS
53%
Loosely correlated
+0.59%
ZTS - VTRS
47%
Loosely correlated
-1.32%
AMRX - VTRS
43%
Loosely correlated
-2.10%
EBS - VTRS
40%
Loosely correlated
-1.72%
COLL - VTRS
37%
Loosely correlated
-6.43%
More